http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1119901-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a045f1ebc0077bddc1b1d8200a579376
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_583aabe4efd16d8a5b6e7aa748cc9c15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ed3f80ccf89fd3457254894b025325a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a4d846ce89b6a8209f65858c9ee9163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b70f223d4148bb20fd0799e8ba271340
publicationDate 2018-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1119901-T1
titleOfInvention SUSPENSIONS OF STONES
abstract The present invention relates generally to compositions and methods for the treatment of cancer and neoplastic disease. There are provided herein substituted compounds of 3-aminopyridine derivatives, substituted 3-aminopyridazine compounds, and pharmaceutical compositions comprising said compounds. The compounds and compositions in question are useful for inhibiting histone deaminases. Further, the compounds and compositions of the invention are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung and / or melanoma cancer and the like.
priorityDate 2012-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422152913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID230373

Total number of triples: 26.